GRAHAM PETER J (EVP General Counsel, Secretary) received a stock award from ANTARES PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/18/2022ACC: 0001016169-22-000016
Officer· EVP General Counsel, Secretary
Since Feb 2019
+9.77K
Net shares
Net buyer
$48.7K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
23.07K acquired · 13.30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+23.07K
Price / share
—
Trade value
—
% of position
3.9%
2/16/2022
594.43K→617.50K
Common Stock
Direct
Shares
−13.30K
Price / share
$3.66
Trade value
$48.67K
% of position
2.2%
2/16/2022
617.50K→604.20K
Total
Net shares
+9.77K
Net value
-$48.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2022 | A · Award | +23.07K | — | — | 3.9% | 594.43K | 617.50K |
| Common Stock Direct | 2/16/2022 | F · Tax Withholding | −13.30K | $3.66 | $48.67K | 2.2% | 617.50K | 604.20K |
| Total | +9.77K | -$48.67K | ||||||
Derivative Transactions0
No derivative transactions reported